Recovery Time in Children With Lower Respiratory Tract Infections Treated With Klacid® Granules for Oral Suspension.

NCT01076166 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 337

Last updated 2011-04-11

Study results available
· View outcomes & findings →

Summary

Klacid Granules for Oral Suspension provides short symptoms' recovery time in Thai children with lower respiratory tract infections.

Conditions

  • Lower Respiratory Tract Infection

Interventions

DRUG

clarithromycin (Klacid) granules for oral suspension

clarithromycin (Klacid) Granules for Oral Suspension

Sponsors & Collaborators

Principal Investigators

  • Savary Om, M.D. · Abbott

Eligibility

Min Age
6 Months
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01076166 on ClinicalTrials.gov